Meet the 10 new Health Incubator Helsinki startups

Meet the 2024 batch of Health Incubator Helsinki teams

Ankerias | Ankerias provides healthcare professionals a digital platform that enhances the treatment of chronic pain patients. Using a pain diary app, data analysis, AI/ML and physiological modelling Ankerias personalises and targets spinal cord stimulation (SCS) pain therapy. Ankerias brings together a unique combination of expertise in the physiology of the pain and artificial intelligence.

EsaDres | EsaDres was founded by the University of Tartu researchers in 2023. EsaDres provides personalised solution for the treatment of chronic wounds by preparing customised high-quality wound dressings for patients in clinics on-demand. Their technology and manufacturing will be automated, validated to achieve the high manufacturing standards at the point of care and the method enables production of various wound dressings according to the needs.

Mind’s Eye | Mind’s Eye is accelerating eye-tracking diagnostics. Mind’s Eye develops optimal and comprehensive eye-tracking solutions for large-scale screening trials and empowers individuals with affordable yet scientific-grade eye tracking at home to help identify deficits and guide interventions.

Natal mind | Natal Mind is a revolutionary, AI-powered birth coach and perinatal mental health support for both parents, always available on their mobile phones. The virtual coach, Natalie follows the Nordic Method: Clinically validated journey to better birth and calmer parenthood. Natalie is following an emotion tracking algorithm developed and tested in Aalto University and connected with wearable data, offering personalised exercises and a future biomarker for perinatal mental health.

NE Device SW | NE Device SW’s Vitacam delivers self-monitoring of vital physiological signs such as respiratory rate, heart rate and oxygen saturation. All this with a mobile app and no other hardware than a smartphone. This enables health providers to save money, by safely discharging less frail patients earlier and gaining efficiencies in the triage of chronic conditions, through remote monitoring.

Otos | Otos is shaping the future with early and profitable hearing care. Their first product, Otoscreen, is a system to help overburdened hearing clinics eliminate and automate cumbersome and costly hearing health diagnosis procedures. This can be done by maintaining or improving the quality of the results, increasing patient throughput, bringing cost-effectiveness, and improving profitability.

RoboMed | RoboMed has innovated a robotic capsule for endoscopy, biopsy and microbiota sampling of the small intestine to diagnose, predict and prevent diseases and disorders with a minimally invasive method. The robotic capsule is working in real-time mode and communicating via a smartphone application while streaming live images and equipped with biopsy needles to perform sampling of the small intestine. Taken samples will be carried out of the body for further examination as well as pathology to diagnose and prevent cancers, diseases and disorders.

SeeTrue Technologies | SeeTrue Technologies develops the world’s most robust eye-tracking solutions and integrates them with manufacturers of vision care, optical microscopes, and AR/VR devices. The significance of eye tracking has surged, making it an indispensable technology for intelligent interactive systems that understand, predict, and react to human behavior.

Solid-IO | Solid-IO is revolutionising cancer care by eliminating guesswork and enhancing accessibility to immunotherapy drugs with a scalable and fast solution. Through the miniaturisation of a patient’s tumour and immune cells in distinctive organ-on-a-chip assays, Solid-IO recreates an individual’s specific antitumor immunity. This empowers oncologists to make informed decisions when choosing personalised treatments for their patients.

Surgerix | Surgerix is the future of microsurgery. Surgerix is developing and pre-commercializing a medical device software solution. Their project is a spin-off from University of Eastern Finland and Kuopio University Hospital Microsurgery Center.